Arrowstreet Capital, Limited Partnership Galapagos Nv Transaction History

Arrowstreet Capital, Limited Partnership

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$52.3 - $71.59 $1.67 Million - $2.29 Million	-31,986 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$51.32 - $68.5 $1.64 Million - $2.19 Million	31,986 New	31,986 $1.98 Million
Q3 2020 Nov 12, 2020	SELL	$122.47 - $213.56 $7.74 Million - $13.5 Million	-63,181 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$185.52 - $231.25 $2.6 Million - $3.24 Million	-13,996 Reduced 18.13%	63,181 $12.5 Million
Q1 2020 May 15, 2020	SELL	$143.0 - $274.03 $359,931 - $689,733	-2,517 Reduced 3.16%	77,177 $15.1 Million
Q4 2019 Feb 13, 2020	BUY	$146.12 - $215.82 $11.6 Million - $17.2 Million	79,694 New	79,694 $16.5 Million
Q1 2019 May 15, 2019	SELL	$89.61 - $117.78 $2.57 Million - $3.38 Million	-28,701 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$87.81 - $110.65 $1.53 Million - $1.93 Million	-17,410 Reduced 37.76%	28,701 $2.63 Million
Q3 2018 Nov 14, 2018	BUY	$90.63 - $120.22 $3.18 Million - $4.22 Million	35,086 Added 318.24%	46,111 $5.18 Million
Q2 2018 Aug 14, 2018	BUY	$88.4 - $105.34 $974,610 - $1.16 Million	11,025 New	11,025 $1.02 Million
Q1 2018 May 14, 2018	SELL	$94.51 - $120.23 $3.68 Million - $4.68 Million	-38,952 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$84.48 - $104.02 $3.29 Million - $4.05 Million	38,952	38,952 $3.65 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.69B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.